1401161-61-2

Upstream product

• 1400984-91-9 N-((R)-1-(naphthalen-1-yl)ethyl)-2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl) acetamide 
• 83549-07-9 4-((2-hydroxyphenyl) amino)-4-oxobut-2-enoic acid 
• 95-55-6 2-amino-phenol 
• 401-81-0 m-trifluoromethylphenyl iodide 
• 1415907-94-6 2-(3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)-N-((R)-1-(naphthalen-1-yl)ethyl)ethanamine 
• 106660-11-1 (3'-oxo-3',4'-dihydro-2'H-1',4'-benzoxazin-2'-yl)acetic acid 

Downstream Products

• 1401075-95-3 (1R)-1-(naphthalen-1-yl)-N-(2-(4-(3-(trifluoromethyl)phenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)ethyl)ethanamine monohydrochloride 

Relevant academic research and scientific papers

BENZO [B] [1, 4] OXAZIN DERIVATIVES AS CALCIUM SENSING RECEPTOR MODULATORS

Compounds of Formula (I) along with processes for their preparation that are useful for treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (Ca SR) receptors. Methods of treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (Ca SR) receptors of Formula (I).